Antithrombotische Therapie nach strukturellen kardialen Interventionen: Empfehlung der Arbeitsgruppe Kardiovaskuläre Hämostase und Antithrombotische Therapie (AG19) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK) in Zusammenarbeit mit der Arbeitsgruppe Interventionelle Kardiologie (AG6) – AGIK und der Arbeitsgruppe Klinische Pharmakologie (AG22) der DGK

Research output: Contribution to journalResearch articleContributedpeer-review


  • Willibald Hochholzer - , University Medical Center Freiburg (Author)
  • Thomas Nührenberg - , University Medical Center Freiburg (Author)
  • Ulrike Flierl - , Hannover Medical School (MHH) (Author)
  • Christoph B. Olivier - , University Medical Center Freiburg (Author)
  • Ulf Landmesser - , Charité – Universitätsmedizin Berlin, Kommission für Klinische Kardiovaskuläre Medizin (Author)
  • Helge Möllmann - , St. Johannes Municipal Hospital (Author)
  • Marcus Dörr - , University of Greifswald (Author)
  • Julinda Mehilli - , Ludwig Maximilian University of Munich (Author)
  • Andreas Schäfer - , Hannover Medical School (MHH) (Author)
  • Daniel Dürschmied - , University Medical Center Freiburg (Author)
  • Dirk Sibbing - , Ludwig Maximilian University of Munich (Author)
  • Ali El-Armouche - , Institute of Pharmacology and Toxicology (Author)
  • Uwe Zeymer - , Klinikum Ludwigshafen (Author)
  • Franz Josef Neumann - , University Medical Center Freiburg (Author)
  • Ingo Ahrens - , Krankenhaus der Augustinerinnen (Author)
  • Tobias Geisler - , University of Tübingen (Author)


In recent years, structural cardiac interventions became an important part of cardiovascular medicine. Despite the rapid development and evolution of these interventional techniques, there is a significant lack of evidence regarding the optimal antithrombotic treatment strategy as randomized trials on this issue are missing for most of these interventions. Thus, this manuscript summarizes the current level of evidence. The listed recommendations are based on available data as well as expert opinion and aim to guide physicians in making decisions for the treatment of patients in this setting.

Translated title of the contribution
Antithrombotic therapy after structural cardiac interventions
Recommendations of the Working Group on Cardiovascular Hemostasis and Antithrombotic Therapy (AG19) of the German Cardiac Society (DGK) in cooperation with the Working Group on Interventional Cardiology (AG6, AGIK) and the Working Group on Clinical Pharmacology (AG22) of the DGK


Original languageGerman
Pages (from-to)57-70
Number of pages14
JournalDer Kardiologe : die Fortbildungszeitschrift der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung
Issue number1
Publication statusPublished - Feb 2021

External IDs

ORCID /0000-0003-2514-9429/work/151437832



  • Dual antiplatelet therapy, MitraClip, Occluder, Oral anticoagulation, TAVI